Literature DB >> 18976246

A web-based clinical record 'xl'Emofilia' for outpatients with haemophilia and allied disorders in the Region of Emilia-Romagna: features and pilot use.

C Pattacini1, G F Rivolta, C Di Perna, F Riccardi, A Tagliaferri.   

Abstract

The treatment of haemophilia in developed countries is based on home self-infusion of concentrates. Improving communication between haemophilia centres (HC) and patients is very important. The Hub Centre (Parma) designed a new outpatient clinical record, 'xl'Emofilia', as part of a project 'Web Connections of the Region's HC' funded by Emilia-Romagna Health Authority. It is a web-based application suited to the needs of HC, which shares the databases of the region's HC, integrated with regional and national registries that can be accessed from anywhere. Data are managed with the 'https' protocol. Significant innovations are 'pathways' that help with the entry of data and 'problem list', which is a summary (updated automatically) of the patient's clinically significant data that can be consulted at a glance. With a 'web identity' (a personal USB key for secure web access), patients can record bleeds and home infusions, consult their own data and allow access to their general practitioners or in emergency departments anywhere in the world (also in English language). In December 2006, the HC started to use 'xl'Emofilia' and 673 clinical records are now active. Since April 2007, 50 pilot patients have been trained and are successfully using the system. A questionnaire administered to these patients on their level of satisfaction with the system and its ease of use gave excellent results. Our web-based system facilitates communication between patients and HC, improves the quality of care and enables patients to use these information at any time and from anywhere in the world.

Entities:  

Mesh:

Year:  2008        PMID: 18976246     DOI: 10.1111/j.1365-2516.2008.01921.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  6 in total

1.  Optimising prophylaxis outcomes and costs in haemophilia patients switching to recombinant FVIII-Fc: a single-centre real-world experience.

Authors:  Annarita Tagliaferri; Annalisa Matichecchia; Gianna F Rivolta; Federica Riccardi; Gabriele Quintavalle; Anna Benegiamo; Rossana Rossi; Antonio Coppola
Journal:  Blood Transfus       Date:  2019-11-04       Impact factor: 3.443

Review 2.  Personal health records: a scoping review.

Authors:  N Archer; U Fevrier-Thomas; C Lokker; K A McKibbon; S E Straus
Journal:  J Am Med Inform Assoc       Date:  2011 Jul-Aug       Impact factor: 4.497

Review 3.  Involving patients in reducing decision uncertainties around orphan and ultra-orphan drugs: a rare opportunity?

Authors:  Devidas Menon; Tania Stafinski; Andrea Dunn; Hilary Short
Journal:  Patient       Date:  2015-02       Impact factor: 3.883

Review 4.  Exploring patient and family involvement in the lifecycle of an orphan drug: a scoping review.

Authors:  Andrea Young; Devidas Menon; Jackie Street; Walla Al-Hertani; Tania Stafinski
Journal:  Orphanet J Rare Dis       Date:  2017-12-22       Impact factor: 4.123

Review 5.  Telehealth Interventions for Improving Self-Management in Patients With Hemophilia: Scoping Review of Clinical Studies.

Authors:  Wenji Qian; Teddy Tai-Ning Lam; Henry Hon Wai Lam; Chi-Kong Li; Yin Ting Cheung
Journal:  J Med Internet Res       Date:  2019-07-10       Impact factor: 5.428

6.  Evaluation of a web-based registry of inherited bleeding disorders: a descriptive study of the Brazilian experience with HEMOVIDAweb Coagulopatias.

Authors:  Suely Meireles Rezende; Silvia Helena Lacerda Rodrigues; Kelly Neves Pinheiro Brito; Diego Lima Quintino da Silva; Marcos Lázaro Santo; Bárbara de Jesus Simões; Guilherme Genovez; Helder Teixeira Melo; João Paulo Baccara Araújo; Danila Augusta Accioly Varella Barca
Journal:  Orphanet J Rare Dis       Date:  2017-02-10       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.